Sunitinib is a multitargeted tyrosine kinase inhibitor associated with idiosyncratic hepatotoxicity. The mechanisms of this toxicity are unknown. We hypothesized that sunitinib undergoes metabolic ...

The annual distribution of reports revealed distinct patterns between sunitinib and ripretinib. Sunitinib-related reports have been submitted consistently since 2006, with a marked increase beginning ...